Edward White
Stock Analyst at HC Wainwright & Co.
(1.98)
# 2,775
Out of 4,814 analysts
402
Total ratings
27.85%
Success rate
-6.08%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $7.90 | +317.72% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $6.78 | +150.74% | 41 | Apr 15, 2025 | |
| INZY Inozyme Pharma | Reiterates: Buy | $16 | $0.92 | +1,630.85% | 14 | Apr 10, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $6.00 | +150.21% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $1.44 | +318.12% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.30 | +1,130.77% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.90 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $4 | $0.41 | +886.44% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $3.14 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $2.23 | +798.88% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.34 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $1.90 | +742.11% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.37 | +365.55% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.06 | +654.72% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.70 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.53 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 | $8.55 | +28.65% | 18 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $38.32 | +43.53% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $11.51 | +343.09% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.86 | +144.76% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $5.06 | +1,007.81% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $10.30 | +200.97% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.22 | - | 12 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.20 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.35 | +7,796.22% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $16.93 | +77.20% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.12 | +971.43% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.90
Upside: +317.72%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $6.78
Upside: +150.74%
Inozyme Pharma
Apr 10, 2025
Reiterates: Buy
Price Target: $16
Current: $0.92
Upside: +1,630.85%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $6.00
Upside: +150.21%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $1.44
Upside: +318.12%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.30
Upside: +1,130.77%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.90
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $4
Current: $0.41
Upside: +886.44%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.14
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $2.23
Upside: +798.88%
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.34
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $1.90
Upside: +742.11%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.37
Upside: +365.55%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.06
Upside: +654.72%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.70
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.53
Upside: -
Mar 5, 2025
Downgrades: Neutral
Price Target: $11
Current: $8.55
Upside: +28.65%
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $38.32
Upside: +43.53%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $11.51
Upside: +343.09%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $2.86
Upside: +144.76%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $5.06
Upside: +1,007.81%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $10.30
Upside: +200.97%
Jun 4, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.22
Upside: -
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.20
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.35
Upside: +7,796.22%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $16.93
Upside: +77.20%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.12
Upside: +971.43%